GEFISTERIS 250
Gefitinib (250mg)
GEFISTERIS 250, containing Gefitinib 250mg, is a crucial medication in the fight against specific types of cancer. As a tyrosine kinase inhibitor, it targets and inhibits the activity of certain proteins involved in the growth and spread of cancer cells, offering a targeted treatment option for patients.
Uses
GEFISTERIS 250 is indicated for the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. It is particularly useful for patients who have not responded well to prior chemotherapy treatments. By targeting the EGFR pathway, Gefitinib helps to control the proliferation of cancer cells, thereby slowing the progression of the disease and improving patient outcomes.
Dosage
The recommended dosage for GEFISTERIS 250 is a single 250mg tablet taken once daily. Consistency is key, so patients should aim to take their dose at the same time each day, with or without food. It is important not to miss doses and to follow the prescribing doctor’s guidance carefully to achieve the best therapeutic results.
Side Effects
Common side effects associated with GEFISTERIS 250 include gastrointestinal issues like diarrhea, skin reactions such as rash or acne, and fatigue. More serious side effects can occur, such as liver toxicity, interstitial lung disease, and severe skin reactions. Patients should report any side effects to their healthcare provider to manage them effectively and adjust treatment if necessary.
Price
The price of GEFISTERIS 250 in India typically ranges between ₹5,000 and ₹7,000 for a monthly supply, depending on the pharmacy and location. Patients should inquire about the cost at different pharmacies and look into possible financial assistance programs to help with the expense.
More Information
GEFISTERIS 250 represents a significant advancement in cancer therapy, particularly for those with EGFR mutation-positive NSCLC. Continuous monitoring and communication with healthcare providers are essential to ensure the treatment is effective and to manage any potential side effects. With proper management, GEFISTERIS 250 can significantly improve the quality of life for many cancer patients. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. Based in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, underscoring its commitment to quality and safety. Sterispharma is dedicated to providing high-quality drugs at affordable prices across India, strictly adhering to WHO guidelines. Sterispharma offers the convenience of an online pharmacy, enabling customers to easily purchase medicines and benefit from home delivery. The company\'s mission is to supply a wide array of healthcare products to meet the diverse needs of the medical community. Whether it\'s advanced treatments, medications for rare conditions, or essential health necessities, Sterispharma strives to serve the broad demands of the healthcare industry. If you need medicine then you can order it on these two websites sterisonline and sterispharma Order Now Sterispharma\'s extensive product lineup includes treatments for various health areas such as Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.
For further information:
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 7877551268, 7849827488
Keywords
same time
wide array
Dental Care
Navi Mumbai
cancer cells
EGFR pathway
broad demands
diverse needs
home delivery
WHO guidelines
monthly supply
liver toxicity
cancer therapy
specific types
online pharmacy
rare conditions
Gefitinib 250mg
General Medicine
Nasal Conditions
patient outcomes
More Information
medical community
affordable prices
proper management
sterispharma Order
Respiratory Issues
high-quality drugs
prescribing doctor
crucial medication
advanced treatments
healthcare industry
healthcare products
healthcare provider
single 250mg tablet
Common side effects
expert professionals
different pharmacies
many cancer patients
various health areas
Continuous monitoring
severe skin reactions
potential side effects
small cell lung cancer
pharmaceutical industry
significant advancement
gastrointestinal issues
specific EGFR mutations
GEFISTERIS 250 Gefitinib
extensive product lineup
best therapeutic results
targeted treatment option
interstitial lung disease
two websites sterisonline
tyrosine kinase inhibitor
More serious side effects
Steris Healthcare Pvt Ltd
EGFR mutation-positive NSCLC
essential health necessities
prior chemotherapy treatments
possible financial assistance programs